Abstract
The HAS issued this opinion in response to the referral from the Director General of Health on 20/04/2021 relating to the possibility of carrying out a vaccination schedule with two mRNA vaccines of different specialties in exceptional situations.
Recommendation
Europe
France
mRNA vaccines
COVID-19